Negative predictive value of pleural fluid cytology in patients with a background of cancer.
O. Castro Anon (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), A. Dudina (Oxford, United Kingdom), Q. Lu (Oxford, United Kingdom), M. Tsikrika (Oxford, United Kingdom), R. Varatharajah (Oxford, United Kingdom), G. Shepherd (Oxford, United Kingdom), A. Thayanandan (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Disease area: Respiratory infections, Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Castro Anon (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), A. Dudina (Oxford, United Kingdom), Q. Lu (Oxford, United Kingdom), M. Tsikrika (Oxford, United Kingdom), R. Varatharajah (Oxford, United Kingdom), G. Shepherd (Oxford, United Kingdom), A. Thayanandan (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). Negative predictive value of pleural fluid cytology in patients with a background of cancer.. 494
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The value of sputum cytology in the diagnosis of lung malignancy Source: Eur Respir J 2007; 30: Suppl. 51, 429s Year: 2007
Negative predictive value of EBUS-TBNA in mediastinal staging of lung cancer Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020
Negative predictive value of EBUS in lung cancer staging Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012
Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Prognosis of patients with NSCLC undergoing positive pleural lavage cytology Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
Could microsatellite analysis of pleural fluid increase sensitivity of pleural fluid cytology? Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007
Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
Negative predictive value of autofluorescence imaging (AFI) in patients at high risk for lung cancer Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007
The diagnostic value of CA-125 in pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001
The value of cytology in pleural effusions vs histology by medical thoracoscopy Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung? Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019
Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013
Assessment of the negative predictive value (NPV) of endobronchial ultrasound-guided real-time needle aspiration (EBUS-rtNA) in mediastinal lymph node staging in patients with lung cancer based on surgical results Source: Annual Congress 2008 - Ways into the mediastinum Year: 2008
Diagnostic value of pleural effusion for the detection of EGFR in NSCLC: a meta-analysis Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019
Shox2, a biomarker for confirming malignancy in bronchial lavage from patients with suspected lung cancer and inconclusive cytology Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009
Rinse fluid cytology specimens add value to standard bronchoscopic sampling techniques in the diagnosis of lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 361s Year: 2003
Diagnostic value of a third pleural biopsy Source: Annual Congress 2005 - What's new in the pleura Year: 2005
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003